Add like
Add dislike
Add to saved papers

On the Border between Low-Nuclearity and One-Dimensional Solids: A Unique Interplay of 1,2,4-Triazolyl-Based {Cu II 5 (OH) 2 } Clusters and Mo VI -Oxide Matrix.

A pentanuclear CuII 5 -hydroxo cluster possessing an unusual linear-shaped configuration was formed and crystallized under hydrothermal conditions as a result of the unique cooperation of bridging 1,2,4-triazole ligand ( trans-1,4-cyclohexanediyl-4,4'-bi(1,2,4-triazole) ( tr2 cy)), MoVI -oxide, and CuSO4 . This structural motif can be rationalized by assuming in situ generation of {Cu2 Mo6 O22 }4- anions, which represent heteroleptic derivatives of γ-type [Mo8 O26 ]4- further interlinked by [Cu3 (OH)2 ]4+ cations through [ N- N] bridges. The framework structure of the resulting compound [Cu5 (OH)2 ( tr2 cy)2 Mo6 O22 ]·6H2 O (1) is thus built up from neutral heterometallic {Cu5 (OH)2 Mo6 O22 } n layers pillared with tetradentate tr2 cy. Quantum-chemical calculations demonstrate that the exclusive site of the parent γ-[Mo8 O26 ]4- cluster into which CuII inserts corresponds with the site that has the lowest defect ("MoO2 vacancy") formation energy, demonstrating how the local metal-polyoxomolybdate chemistry can express itself in the final crystal structure. Magnetic susceptibility measurements of 1 show strong antiferromagnetic coupling within the Cu5 chain with exchange parameters J1 = -500(40) K (-348(28) cm-1 ), J2 = -350(10) K (-243(7) cm-1 ) and g = 2.32(2), χ2 = 6.5 × 10-4 . Periodic quantum-chemical calculations reproduce the antiferromagnetic character of 1 and connect it with an effective ligand-mediated spin coupling mechanism that comes about from the favorable structural arrangement between the Cu centers and the OH- , O2- , and tr2 cy bridging ligands.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app